v3.26.1
Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Mar. 31, 2026
Cash flows from operating activities      
Net loss per share attributable to Ordinary shareholders $ (9,794,375) $ (4,005,770) $ (22,516,222)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 729,516 125,000  
Stock based compensation 75,376 71,358  
Deferred income taxes (16,118) (1,289)  
Unrealized foreign exchange loss/(profit) 109,427 (9,456)  
Expenses settled through issuance of equity shares 812,288  
Fair value losses in financial instruments carried at fair value 7,210,865 511,538  
Expected credit loss (net of reversal) (1,540,122) 198,749  
Balances written Off/(back) (1,793,721)  
Net loss attributable to non-controlling interest, net of tax 30,240 (95,337)  
Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions:      
Inventories (72,073) 103,415  
Accounts receivables, net 159,750 (147,930)  
Prepayments and other assets (2,082,810) (2,071,466)  
Accounts payable and accrued expenses 245,637 2,323,205  
Other liabilities 452,958 76,478  
Net cash used in operating activities (5,473,162) (2,921,507)  
Cash flows from investing activities      
Purchase of property and equipment, intangible assets and goodwill (464,491) (274,056)  
Consideration paid for business acquired in prior year (925,000)  
Investment in mutual funds and bonds (1,515)  
Proceeds from sale of mutual fund 73,116  
Net cash used in investing activities (1,391,006) (200,940)  
Cash flows from financing activities      
Proceeds from issue of ordinary shares 7,460,000 1,386,959  
Net proceeds/(payments) from short-term borrowings (1,175,305) 49,990  
Net cash generated from financing activities 6,284,695 1,436,949  
Effect of exchange rate changes on cash and cash equivalents (24,586)  
Net (decrease)/increase in cash and cash equivalents (including restricted cash) (579,473) (1,710,084)  
Cash and cash equivalents at the beginning of the period (including restricted cash) 6,800,620 5,053,654 5,053,654
Total cash and cash equivalents 6,221,147 3,343,570 6,800,620
Reconciliation of cash and cash equivalents      
Cash and cash equivalents 6,004,085 3,124,856 6,578,594
Restricted cash 217,062 218,714 $ 222,026
Supplemental disclosure of cash flow information      
Cash paid for interest, net of amounts capitalized 1,821,711 1,001,397  
Non-cash investing and financing activities      
Consideration payable in connection with acquisitions 1,074,070 8,376,253  
Interest accrued on borrowings $ 4,941,475 $ 2,089,465